Abstract
Aim
The aim of our study was to carry out a literature review and develop a model illustrating the domains of patients’ lives that are impacted by herpes zoster (HZ) and subsequent chronic pain.
Subjects and methods
Biomedical databases and online congress archives were searched using keywords related to HZ or post-herpetic neuralgia (PHN) and social, psychological or physical impact. A total of 733 abstracts were reviewed, and 29 publications containing concepts reported by patients were retained for the model. Wilson and Cleary’s model was used to organise the findings. Links between concepts were documented on three levels: hypothesis, observation and evidence. The final model illustrates the concepts impacted by HZ and PHN, relationships between these concepts and the level of evidence identified.
Results
The concepts identified from the articles were grouped into the following categories: biological/physiological, symptom status, functional status, health perceptions, characteristics of the individual, health-related quality of life (HRQOL), treatment and characteristics of the environment. Evidence exists showing that HZ-related pain directly impacts functional status, health perceptions and HRQOL.
Conclusion
Patients report that all major domains of life are impaired by HZ or subsequent chronic pain. HZ and its painful and debilitating complications can have a substantial impact on physical, psychological, social and role functioning, HRQOL and activities of daily living. The impact on elderly patients needs to be further assessed with appropriately designed and validated instruments, with specific attention paid to dependence.
Similar content being viewed by others
References
Acquadro C, Berzon R, Dubois D, Leidy NK, Marquis P, Revicki D, Rothman M (2003) Incorporating the patient's perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) harmonization group meeting at the Food and Drug Administration, February 16, 2001. Value Health 6:522–531
Binder A, Koroschetz J, Baron R (2008) Disease mechanisms in neuropathic itch. Nat Clin Pract Neurol 4:329–337
Bowsher D (1999) The lifetime occurrence of herpes zoster and prevalence of post-herpetic neuralgia: a retrospective survey in an elderly population. Eur J Pain 3:335–342
Brisson M, Edmunds WJ (2003) Epidemiology of varicella-zoster virus in England and Wales. J Med Virol 70(Suppl 1):S9–S14
Chapman RS, Cross KW, Fleming DM (2003) The incidence of shingles and its implications for vaccination policy. Vaccine 21:2541–2547
Chassany O, Sagnier P, Marquis P, Fullerton S, Aaronson N (2002) Patient-reported outcomes: the example of health-related quality of life—a European guidance document for the improved integration of health-related quality of life assessment in the drug regulatory process. Drug Inf J 36:209–238
Chidiac C, Bruxelle J, Daures JP, Hoang-Xuan T, Morel P, Leplege A, El Hasnaoui A, de Labareyte C (2001) Characteristics of patients with herpes zoster on presentation to practitioners in France. Clin Infect Dis 33:62–69
Clark MR, Heinberg LJ, Haythornthwaite JA, Quatrano-Piacentini AL, Pappagallo M, Raja SN (2000) Psychiatric symptoms and distress differ between patients with postherpetic neuralgia and peripheral vestibular disease. J Psychosom Res 48:51–57
Committee for Medicinal Products for Human Use, CHMP (2007) Guideline on clinical medicinal products intended for the treatment of neuropathic pain. Accessed 16 December 2009
Coplan PM, Schmader K, Nikas A, Chan IS, Choo P, Levin MJ, Johnson G, Bauer M, Williams HM, Kaplan KM, Guess HA, Oxman MN (2004) Development of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventory. J Pain 5:344–356
Cunningham AL, Breuer J, Dwyer DE, Gronow DW, Helme RD, Litt JC, Levin MJ, Macintyre CR (2008) The prevention and management of herpes zoster. Med J Aust 188:171–176
Dworkin RH, Hartstein G, Rosner HL, Walther RR, Sweeney EW, Brand L (1992) A high-risk method for studying psychosocial antecedents of chronic pain: the prospective investigation of herpes zoster. J Abnorm Psychol 101:200–205
Dworkin RH, Johnson RW, Breuer J, Gnann JW, Levin MJ, Backonja M, Betts RF, Gershon AA, Haanpaa ML, McKendrick MW, Nurmikko TJ, Oaklander AL, Oxman MN, Pavan-Langston D, Petersen KL, Rowbotham MC, Schmader KE, Stacey BR, Tyring SK, van Wijck AJ, Wallace MS, Wassilew SW, Whitley RJ (2007) Recommendations for the management of herpes zoster. Clin Infect Dis 44(Suppl 1):S1–S26
Dwyer DE, Cunningham AL (2002) 10: herpes simplex and varicella-zoster virus infections. Med J Aust 177:267–273
Farrell MJ, Gerontol M, Gibson SJ, Helme RD (1995) The effect of medical status on the activity level of older pain clinic patients. J Am Geriatr Soc 43:102–107
Fields HL, Rowbotham M, Baron R (1998) Postherpetic neuralgia: irritable nociceptors and deafferentation. Neurobiol Dis 5:209–227
Gauthier A, Breuer J, Carrington D, Martin M, Remy V (2008) Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect 1–10
Giannakouris K (2008) Ageing characterises the demographic perspectives of the European societies. Accessed 16 December 2009
Gnann JW Jr (2008) Vaccination to prevent herpes zoster in older adults. J Pain 9:S31–S36
Goh CL, Khoo L (1997) A retrospective study of the clinical presentation and outcome of herpes zoster in a tertiary dermatology outpatient referral clinic. Int J Dermatol 36:667–672
Haythornthwaite JA, Clark MR, Pappagallo M, Raja SN (2003) Pain coping strategies play a role in the persistence of pain in post-herpetic neuralgia. Pain 106:453–460
Hope-Simpson RE (1965) The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 58:9–20
Johnson RW (1995) The future of predictors, prevention, and therapy in postherpetic neuralgia. Neurology 45:S70–S72
Johnson R (2001) Herpes zoster—predicting and minimizing the impact of post-herpetic neuralgia. J Antimicrob Chemother 47(Suppl T1):1–8
Johnson RW (2004) Pain following herpes zoster: implications for management. Herpes 11(3):63–65
Johnson RW, Rice AS (2007) Pain following herpes zoster: the influence of changing population characteristics and medical developments. Pain 128:3–5
Johnson RW, Wasner G, Saddier P, Baron R (2007) Postherpetic neuralgia: epidemiology, pathophysiology and management. Expert Rev Neurother 7:1581–1595
Johnson RW, Wasner G, Saddier P, Baron R (2008) Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient. Drugs Aging 25:991–1006
Katz J, Cooper EM, Walther RR, Sweeney EW, Dworkin RH (2004) Acute pain in herpes zoster and its impact on health-related quality of life. Clin Infect Dis 39:342–348
Katz J, McDermott MP, Cooper EM, Walther RR, Sweeney EW, Dworkin RH (2005) Psychosocial risk factors for postherpetic neuralgia: a prospective study of patients with herpes zoster. J Pain 6:782–790
Lydick E, Epstein RS, Himmelberger D, White CJ (1995) Area under the curve: a metric for patient subjective responses in episodic diseases. Qual Life Res 4:41–45
Marquis P, Arnould B, Acquadro C, Roberts WM (2006) Patient-reported outcomes and health-related quality of life in effectiveness studies: pros and cons. Drug Dev Res 67:193–201
Mauskopf J, Austin R, Dix L, Berzon R (1994) The Nottingham Health Profile as a measure of quality of life in zoster patients: convergent and discriminant validity. Qual Life Res 3:431–435
Meyer-Rosberg K, Burckhardt CS, Huizar K, Kvarnstrom A, Nordfors LO, Kristofferson A (2001) A comparison of the SF-36 and Nottingham Health Profile in patients with chronic neuropathic pain. Eur J Pain 5:391–403
Miller E, Marshall R, Vurdien J (1993) Epidemiology, outcome and control of varicella-zoster infection. Rev Med Micro-biol 4:222–230
Neumann L, Berzak A, Buskila D (2000) Measuring health status in Israeli patients with fibromyalgia syndrome and widespread pain and healthy individuals: utility of the short form 36-item health survey (SF-36). Semin Arthritis Rheum 29:400–408
Oster G, Dukes E, Edelsberg J, Cleary P (2004) Relationship between pain and perceived health status in older persons with post-herpetic neuralgia. International Society for Pharmacoeconomics and Outcomes Research; 9th Annual International Meeting. Arlington, VA. Value in Health.
Oxman MN (2000) Clinical manifestations of herpes zoster. In: Arvin A, Gershon AA (eds) Varicella-zoster virus. Virology and clinical management. Cambridge University Press, Cambridge, pp 246–275
Oxman MN, Levin MJ (2008) Vaccination against herpes zoster and postherpetic neuralgia. J Infect Dis 197(Suppl 2):S228–S236
Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, Weinberg A, Boardman KD, Williams HM, Zhang JH, Peduzzi PN, Beisel CE, Morrison VA, Guatelli JC, Brooks PA, Kauffman CA, Pachucki CT, Neuzil KM, Betts RF, Wright PF, Griffin MR, Brunell P, Soto NE, Marques AR, Keay SK, Goodman RP, Cotton DJ, Gnann JW Jr, Loutit J, Holodniy M, Keitel WA, Crawford GE, Yeh SS, Lobo Z, Toney JF, Greenberg RN, Keller PM, Harbecke R, Hayward AR, Irwin MR, Kyriakides TC, Chan CY, Chan IS, Wang WW, Annunziato PW, Silber JL (2005) A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med 352:2271–2284
Patrick DL, Burke LB, Powers JH, Scott JA, Rock EP, Dawisha S, O'Neill R, Kennedy DL (2007) Patient-reported outcomes to support medical product labeling claims: FDA perspective. Value Health 10(Suppl 2):S125–S137
Rowbotham MC, Petersen KL (2001) Zoster-associated pain and neural dysfunction. Pain 93:1–5
Schipper H (1990) Guidelines and caveats for quality of life measurement in clinical practice and research. Oncology (Williston Park) 4:51–57
Schmader K (1999) Herpes zoster in the elderly: issues related to geriatrics. Clin Infect Dis 28:736–739
Schmader K (2001) Herpes zoster in older adults. Clin Infect Dis 32:1481–1486
Schmader K, Dworkin RH (2008) Natural history and treatment of herpes zoster. J Pain 9:S3–S9
Schmader K, George LK, Burchett BM, Pieper CF (1998) Racial and psychosocial risk factors for herpes zoster in the elderly. J Infect Dis 178(Suppl 1):S67–S70
Schmader K, Studenski S, MacMillan J, Grufferman S, Cohen HJ (1990) Are stressful life events risk factors for herpes zoster? J Am Geriatr Soc 38:1188–1194
Schmader KE, Sloane R, Pieper C, Coplan PM, Nikas A, Saddier P, Chan IS, Choo P, Levin MJ, Johnson G, Williams HM, Oxman MN (2007) The impact of acute herpes zoster pain and discomfort on functional status and quality of life in older adults. Clin J Pain 23:490–496
Scott FT, Johnson RW, Leedham-Green M, Davies E, Edmunds WJ, Breuer J (2006) The burden of herpes zoster: a prospective population based study. Vaccine 24:1308–1314
Spilker B (1990) Introduction to the field of quality of life trials. In: Spilker B (ed) Quality of life assessments in clinical trials. Raven Press, New York, pp 3–10
Sullivan MJ, Lynch ME, Clark AJ (2005) Dimensions of catastrophic thinking associated with pain experience and disability in patients with neuropathic pain conditions. Pain 113:310–315
van Seventer R, Sadosky A, Lucero M, Dukes E (2006) A cross-sectional survey of health state impairment and treatment patterns in patients with postherpetic neuralgia. Age Ageing 35:132–137
Vetter TR (2007) A primer on health-related quality of life in chronic pain medicine. Anesth Analg 104:703–718
Wareham DW, Breuer J (2007) Herpes zoster. BMJ 334:1211–1215
Wilson IB, Cleary PD (1995) Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA 273:59–65
Wolfe F, Hawley DJ (1997) Measurement of the quality of life in rheumatic disorders using the EuroQol. Br J Rheumatol 36:786–793
Wu CL, Raja SN (2008) An update on the treatment of postherpetic neuralgia. J Pain 9:S19–S30
Acknowledgements
We thank Nicola Barnes and Isabelle Guillemin for their contribution to the development of the manuscript and Claire Marant for performing the literature search.
Conflict of interest
This work was funded partly by Sanofi Pasteur, MSD. Khadra Benmedjahed and Benoit Arnould are paid consultants employed by Mapi Values. Special thanks to Angus Thomson for his thorough review of the different versions of this paper.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Arnould, B., Benmedjahed, K., Gallais, JL. et al. The impact of herpes zoster and subsequent chronic pain on patients’ daily lives. J Public Health 18, 567–574 (2010). https://doi.org/10.1007/s10389-010-0346-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10389-010-0346-6